Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-25-059489
Filing Date
2025-06-13
Accepted
2025-06-13 18:00:54
Documents
1
Period of Report
2025-06-11

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2517929-1_4seq1.html 4  
1 OWNERSHIP DOCUMENT tm2517929-1_4seq1.xml 4 11261
  Complete submission text file 0001104659-25-059489.txt   13990
Mailing Address ONE LETTERMAN DRIVE BUILDING D, SUITE D3-300 SAN FRANCISCO CA 94129
Business Address ONE LETTERMAN DRIVE BUILDING D, SUITE D3-300 SAN FRANCISCO CA 94129 415-489-9980
Redmile Group, LLC (Reporting) CIK: 0001425738 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-39071 | Film No.: 251047940

Mailing Address 45 W. 27TH STREET, FLOOR 11 NEW YORK NY 10001
Business Address
Green Jeremy (Reporting) CIK: 0001650527 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39071 | Film No.: 251047939

Mailing Address BIOPOLE ROUTE DE LA CORNICHE 3B EPALINGES V8 1066
Business Address BIOPOLE ROUTE DE LA CORNICHE 3B EPALINGES V8 1066 41 21 653 02 00
ADC Therapeutics SA (Issuer) CIK: 0001771910 (see all company filings)

EIN.: 000000000 | State of Incorp.: V8 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address ONE LETTERMAN DRIVE, BLDG D, STE D3-300 SAN FRANCISCO CA 94129
Business Address C/O MAPLES CORPORATE SERVICES LIMITED PO BOX 309, UGLAND HOUSE GEORGE TOWN, GRAND CAYMAN E9 KY1-1104 4154899980
RedCo II Master Fund, L.P. (Reporting) CIK: 0001921783 (see all company filings)

State of Incorp.: E9 | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-39071 | Film No.: 251047938